Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Colchicine on Coronary Reperfusion in ACS
NCT05472337Phase 2Recruiting
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Aug 2022
- Primary completion
- Mar 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in acute coronary syndrome (ACS), sponsored by Pontificia Universidad Católica de Chile. Started Aug 2022; status: recruiting.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT05472337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05472337.